176 related articles for article (PubMed ID: 37848981)
21. Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling.
Yang Q; Zhao S; Shi Z; Cao L; Liu J; Pan T; Zhou D; Zhang J
J Exp Clin Cancer Res; 2021 Apr; 40(1):120. PubMed ID: 33823894
[TBL] [Abstract][Full Text] [Related]
22. Tumor-derived exosomal BCYRN1 activates WNT5A/VEGF-C/VEGFR3 feedforward loop to drive lymphatic metastasis of bladder cancer.
Zheng H; Chen C; Luo Y; Yu M; He W; An M; Gao B; Kong Y; Ya Y; Lin Y; Li Y; Xie K; Huang J; Lin T
Clin Transl Med; 2021 Jul; 11(7):e497. PubMed ID: 34323412
[TBL] [Abstract][Full Text] [Related]
23. SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88.
Dong H; Wang W; Mo S; Chen R; Zou K; Han J; Zhang F; Hu J
J Exp Clin Cancer Res; 2018 Aug; 37(1):202. PubMed ID: 30157918
[TBL] [Abstract][Full Text] [Related]
24. Correlation between long non-coding RNAs (lncRNAs) H19 expression and trastuzumab resistance in breast cancer.
Sun Z; Zhang C; Wang T; Shi P; Tian X; Guo Y
J Cancer Res Ther; 2019; 15(4):933-940. PubMed ID: 31436255
[TBL] [Abstract][Full Text] [Related]
25. LINC00969 promotes the degeneration of intervertebral disk by sponging miR-335-3p and regulating NLRP3 inflammasome activation.
Yu L; Hao Y; Xu C; Zhu G; Cai Y
IUBMB Life; 2019 May; 71(5):611-618. PubMed ID: 30592131
[TBL] [Abstract][Full Text] [Related]
26. Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer.
Zhang Z; Zhang L; Yu G; Sun Z; Wang T; Tian X; Duan X; Zhang C
Cancer Chemother Pharmacol; 2020 Dec; 86(6):761-772. PubMed ID: 33068176
[TBL] [Abstract][Full Text] [Related]
27. Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell proliferation and invasion by regulating miR-15a-5p/HMGA2 axis.
Zhang Y; Luo G; You S; Zhang L; Liang C; Chen X
Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):673-682. PubMed ID: 33882126
[TBL] [Abstract][Full Text] [Related]
28. LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis.
Hu YP; Jin YP; Wu XS; Yang Y; Li YS; Li HF; Xiang SS; Song XL; Jiang L; Zhang YJ; Huang W; Chen SL; Liu FT; Chen C; Zhu Q; Chen HZ; Shao R; Liu YB
Mol Cancer; 2019 Nov; 18(1):167. PubMed ID: 31752906
[TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA CERS6-AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA.
Bao G; Huang J; Pan W; Li X; Zhou T
Cancer Med; 2020 Jan; 9(1):278-289. PubMed ID: 31701672
[TBL] [Abstract][Full Text] [Related]
30. CircRNA, lncRNA, and mRNA profiles of umbilical cord blood exosomes from preterm newborns showing bronchopulmonary dysplasia.
Wang Y; Wang X; Xu Q; Yin J; Wang H; Zhang L
Eur J Pediatr; 2022 Sep; 181(9):3345-3365. PubMed ID: 35790551
[TBL] [Abstract][Full Text] [Related]
31. Exosomal long noncoding RNA AGAP2-AS1 regulates trastuzumab resistance via inducing autophagy in breast cancer.
Qian X; Qu H; Zhang F; Peng S; Dou D; Yang Y; Ding Y; Xie M; Dong H; Liao Y; Han M
Am J Cancer Res; 2021; 11(5):1962-1981. PubMed ID: 34094664
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer-derived exosomes transmit lncRNA SNHG16 to induce CD73+γδ1 Treg cells.
Ni C; Fang QQ; Chen WZ; Jiang JX; Jiang Z; Ye J; Zhang T; Yang L; Meng FB; Xia WJ; Zhong M; Huang J
Signal Transduct Target Ther; 2020 Apr; 5(1):41. PubMed ID: 32345959
[TBL] [Abstract][Full Text] [Related]
33. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
34. LncRNA LINC00969 promotes acquired gefitinib resistance by epigenetically suppressing of NLRP3 at transcriptional and posttranscriptional levels to inhibit pyroptosis in lung cancer.
Dai J; Qu T; Yin D; Cui Y; Zhang C; Zhang E; Guo R
Cell Death Dis; 2023 May; 14(5):312. PubMed ID: 37156816
[TBL] [Abstract][Full Text] [Related]
35. LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361-3p and HuR to drive cervical cancer progression.
Xu J; Yang B; Wang L; Zhu Y; Zhu X; Xia Z; Zhao Z; Xu L
Cell Prolif; 2020 Jul; 53(7):e12823. PubMed ID: 32515533
[TBL] [Abstract][Full Text] [Related]
36. Integrative bioinformatics analysis reveals miR-494 and its target genes as predictive biomarkers of trastuzumab-resistant breast cancer.
Hermawan A; Putri H
J Egypt Natl Canc Inst; 2020 Apr; 32(1):16. PubMed ID: 32372307
[TBL] [Abstract][Full Text] [Related]
37. NCAPG confers trastuzumab resistance via activating SRC/STAT3 signaling pathway in HER2-positive breast cancer.
Jiang L; Ren L; Chen H; Pan J; Zhang Z; Kuang X; Chen X; Bao W; Lin C; Zhou Z; Huang D; Yang J; Huang H; Wang L; Hou N; Song L
Cell Death Dis; 2020 Jul; 11(7):547. PubMed ID: 32683421
[TBL] [Abstract][Full Text] [Related]
38. Potential role of CXCR4 in trastuzumab resistance in breast cancer patients.
Kotb RM; Ibrahim SS; Mostafa OM; Shahin NN
Biochim Biophys Acta Mol Basis Dis; 2022 Nov; 1868(11):166520. PubMed ID: 35985446
[TBL] [Abstract][Full Text] [Related]
39. Identification of exosomal miR-455-5p and miR-1255a as therapeutic targets for breast cancer.
Xin Y; Wang X; Meng K; Ni C; Lv Z; Guan D
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31763681
[TBL] [Abstract][Full Text] [Related]
40. CRC-derived exosomes containing the RNA binding protein HuR promote lung cell proliferation by stabilizing c-Myc mRNA.
Xiao H; Ye X; Vishwakarma V; Preet R; Dixon DA
Cancer Biol Ther; 2022 Dec; 23(1):139-149. PubMed ID: 35130122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
